Northrop Grumman to Begin Production of RQ-4 Global Hawk UAS for Republic of Korea

Northrop Grumman Corporation will begin production of four RQ-4 Global Hawk unmanned aircraft systems (UAS) for the Republic of Korea's Air Force. The systems will provide valuable wide-area intelligence gathering capabilities to military commanders so they can make more informed decisions.

Under a contract awarded Dec. 16, the company will work closely with the U.S. Air Force to deliver the systems starting in 2018.

"It's clear that U.S. allies have seen the critical role Global Hawk plays for the U.S. Air Force around the world," said Mary Petryszyn, vice president, International, Northrop Grumman Aerospace Systems. "The system will be a vital link in the Republic of Korea's increasing leadership role in defending the peninsula."

The contract is for four aircraft, two ground stations and supporting equipment that allows Republic of Korea Air Force operators to control and maintain the system.

"This is a significant achievement for Northrop Grumman because it represents the first time a Global Hawk has been sold to an allied nation in the Asia-Pacific region under the Foreign Military Sales process," said Mary Petryszyn.

The contract announcement follows significant procurement decisions made by the Japanese and Australian governments to purchase the Global Hawk and the MQ-4C Triton – comprising Northrop Grumman's family of high-altitude, long-endurance UAS.

Northrop Grumman is a leading global security company providing innovative systems, products and solutions in unmanned systems, cyber, C4ISR, and logistics and modernization to government and commercial customers worldwide. Please visit www.northropgrumman.com for more information.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.